Evidence map›Paper›PMID 25352631›Full record

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2014

Diagnosis and treatment of invasive fungal infections in the cancer patient: recent progress and ongoing questions.

Dimitrios P Kontoyiannis, Thomas F Patterson

Abstract readReview
In one paragraph

Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Evaluation of anAntimicrobial agents and chemotherapy · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Invasive fungal infections in hematologic malignancies: Incidence, management, and antifungal therapy.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2023
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dimitrios P KontoyiannisDivision of Internal Medicine, University of Texas M. D. Anderson Cancer Center, Houston Department of Medicine, University of Texas Health Science Center at San Antonio, and South Texas Veterans Health Care System.
Thomas F PattersonDivision of Internal Medicine, University of Texas M. D. Anderson Cancer Center, Houston Department of Medicine, University of Texas Health Science Center at San Antonio, and South Texas Veterans Health Care System.

Funding

The third infections in cancer symposiumR13HS021599 · AHRQ · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI RAAD, ISSAM INAAM · 2012 to 2012
$45k
AHRQ HHS R13 HS021599
6 · The paper itself

Abstract

In the last 5 years we have witnessed further developments in diagnosis and treatment of invasive fungal infections (IFIs) that complicate cancer chemotherapy. In this brief overview, we highlight some advancement, discuss future directions, and unmet needs in this complex area.

Indexed as

Antifungal AgentsAspergillosisCandidiasisHumansMycosesNeoplasmsAntifungal AgentsAspergillosiscancercandidiasisdiagnosistreatment

Identifiers

PMID25352631
PMCPMC4303053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.